Recent Clinical Evidence in Bisphosphonate-related Osteomyelitis of the Jaw: Focus on Risk, Prevention and Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|9|1|37-52

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.9, Iss.1, 2014-01, pp. : 37-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of bisphosphonate‐related osteonecrosis of the jaw: a literature review

By  

ORAL DISEASES, Vol. 21, Iss. 8, 2015-11 ,pp. : 927-936

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Case of Autoimmune Hepatitis and Bisphosphonate-Related Osteonecrosis of the Jaw

By  

Case Reports in Gastroenterology, Vol. 6, Iss. 2, 2012-05 ,pp. : 309-313

Karger

Access to resources Recommend Favorite

Immune cellular profile of bisphosphonate‐related osteonecrosis of the jaw

By  

ORAL DISEASES, Vol. 22, Iss. 7, 2016-10 ,pp. : 649-657

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence and Risk Factors of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients Having Undergone Autologous Stem Cell Transplantation

By  

Oncology Research and Treatment, Vol. 35, Iss. 11, 2012-10 ,pp. : 658-664

Karger

Access to resources Recommend Favorite

Insight into bisphosphonate-associated osteomyelitis of the jaw: pathophysiology, mechanisms and clinical management

By Wimalawansa Sunil J  

Expert Opinion on Drug Safety, Vol. 7, Iss. 4, 2008-07 ,pp. : 491-512

Informa Healthcare

Access to resources Recommend Favorite